RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:252018

Teratoma of the central nervous system

high confidenceSubtype of disorder

Publications

58

50.1th percentile

Trials

6

Interventional, condition-specific

Researchers

375

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (6)

CNS teratoma · central nervous system teratoma · teratoma of CNS · teratoma of central nervous system · teratoma of the CNS · teratoma of the central nervous system

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    58 matched papers (41 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    6 matched on ClinicalTrials.gov

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

58

58 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

58 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

41 in the last 10 years · high confidence · 50.1th percentile (publications denominator)

Phrase hits: 58 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

375

Distinct author names in 58 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Brito VN2 papers · 2023

    Discipline of Endocrinology & Metabolism, Department of Internal Medicine, University of Sao Paulo Medical School, University of Sao Paulo, Sao Paulo 01246 903, Brazil.

    Papers in Europe PMC
  2. 02
    Kim SK2 papers · 2014

    Division of Pediatric Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.

    Papers in Europe PMC
  3. 03
    Lehrnbecher T2 papers · 2021

    Division of Pediatric Hematology and Oncology, Hospital for Children and Adolescents, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.

    Papers in Europe PMC
  4. 04
    Liu L2 papers · 2024

    Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, China.

    Papers in Europe PMC
  5. 05
    Mirchia K2 papers · 2022

    Department of Radiology, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA.

    Papers in Europe PMC
  6. 06
    Park SH2 papers · 2014

    Department of Pathology, Seoul National University College of Medicine, Seoul, Korea. ; Neuroscience Institute, Seoul National University College of Medicine, Seoul, Korea.

    Papers in Europe PMC
  7. 07
    A'Hern RP1 paper · 1990
    Papers in Europe PMC
  8. 08
    Abdali H1 paper · 2021

    Department of Surgery, School of Medicine, Craniofacial and Cleft Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

    Papers in Europe PMC
  9. 09
    Abramov I1 paper · 2025

    The Loyal and Edith Davis Neurosurgical Research Laboratory, Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.

    Papers in Europe PMC
  10. 10
    Abramowsky CR1 paper · 2007
    Papers in Europe PMC

Clinical research

Is a treatment being tested?

6

interventional trials for this specific condition

6 interventional trials matched this specific condition name; none in our sample are currently recruiting. 21 trials are registered for teratoma, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

6 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 89th percentile).

high confidence · 89th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

6 interventional trials matched after quoted-phrase search and title/condition post-filter.

No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.

Broader category: teratoma

21

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Teratoma of the central nervous system" OR "Teratoma of central nervous system" OR "CNS teratoma" OR "central nervous system teratoma" OR "teratoma of CNS" OR "teratoma of the CNS"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Teratoma of the central nervous system" OR "Teratoma of central nervous system" OR "CNS teratoma" OR "central nervous system teratoma" OR "teratoma of CNS" OR "teratoma of the CNS"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 6 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"teratoma"

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T10:58:05.609Z